IL-18 BINDING PROTEINS

The present invention encompasses IL-18 binding proteins, particularly antibodies that bind human interleukin-18 (hIL-18). Specifically, the invention relates to antibodies that are entirely human antibodies. Preferred antibodies have high affinity for hIL-18 and/or that neutralize hIL-18 activity i...

Full description

Saved in:
Bibliographic Details
Main Authors JIA XIAO CHI, KANG JASPAL SINGH, WIELER JAMES, VOSS JEFFREY W, LABKOVSKY BORIS, HEDBERG BRAD, BABCOOK JOHN, GREEN LARRY, GHAYUR TARIQ
Format Patent
LanguageEnglish
Korean
Published 18.12.2012
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention encompasses IL-18 binding proteins, particularly antibodies that bind human interleukin-18 (hIL-18). Specifically, the invention relates to antibodies that are entirely human antibodies. Preferred antibodies have high affinity for hIL-18 and/or that neutralize hIL-18 activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. Method of making and method of using the antibodies of the invention are also provided. The antibodies, or antibody portions, of the invention are useful for detecting hIL-18 and for inhibiting hIL-18 activity, e.g., in a human subject suffering from a disorder in which hIL-18 activity is detrimental.
Bibliography:Application Number: KR20127028781